Work

Abstract CT130: Neoadjuvant botensilimab plus balstilimab in MMR proficient and deficient early stage cancers: First results of the pan-cancer NEOASIS study

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct130

Authors: Peter G. de Gooyer, Lauren D. van den Dungen, Marnix H. Geukes Foppen, Cecile Grootscholten, Simone Dokter, Thomas R. de Wijkerslooth, Brechtje A. Grotenhuis, Caroline A. Drukker, Winan J. van Houdt, Sara Balduzzi, John B. Haanen, José G. van den Berg, Marleen Kok, Myriam Chalabi

Institution: The Netherlands Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822286

Cites:

Cited by: 1

Related to: 10